HOME > PRODUCT DISPLAY > Knowledge > TXL

Tongxinluo reduces myocardial no-reflow and ischemia

2014-04-17 07:17:44
Reading Volume:156

 Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway

 

All the above contents are at www.yiling.cn. Do not reproduce them without authorization. Please send an email to www@yiling.cn for authorization.

Copyright: Shijiazhuang Yiling pharmaceutical Limited by Share Ltd

XML 地图 | Sitemap 地图